National Council for Behavioral Health

Skip to content
Find a Provider
The National Council logo

Pharmaceutical companies, Adapt Pharma and Kaléo, are donating doses of naloxone, a potentially lifesaving drug that can help reverse opioid overdoses, to the National Council.


Donation Criteria

If your organization is interested in receiving a donation of naloxone, please complete the brief questionnaire in the link below. To receive a donation, an organization must meet the following requirements:

  • Be a current National Council member
  • Provide residential substance use treatment for people with an opioid use disorder (This requirement is only for organizations that would like to receive the auto-injector formulation, because we encourage you to give the naloxone medication to patients at discharge.)
  • Participation in an informational webinar on the proper administration of the medication to take place in July

Your organization will need to select your preference of either the nasal spray or auto-injector formulation in the questionnaire. Please note that completing the questionnaire does not guarantee your organization will receive a donation, or that your organization will receive the amount requested. Organizations will initially be limited to a maximum of 50 cartons of either formulation, however additional donations will be provided pending availability. To be considered, please complete the questionnaire by June 18th, 2018. Click here to complete the Questionnaire.


A message from the Surgeon General

Read More

Learn more about this exciting initiative in our press release from April 25, 2018.


Additional Resources

Adapt Pharma